Photo of Luciano J Costa from X
Jul 28, 2024, 07:55
Luciano J Costa: MRD accelerating myeloma drug development
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Luciano J Costa, Professor of Medicine at the University of Alabama on X, adding:
“Such an elegantly written paragraph in Blood Journal by Luciano J Costa discussing MRD in myeloma (commentary on C. Ola Landgren et al’s work!)
We talk about MRD negativity as a surrogate for OS… in a sense, sCR is a surrogate for MRD negativity!”
Quoting Luciano J Costa‘s post:
“MRD accelerating myeloma drug development – My taken on the landmark EVIDENCE work from C. Ola Landgren and team.”
Read Further.
Source: Rahul Banerjee/X and Luciano J Costa/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 18, 2025, 19:26
Apr 18, 2025, 18:48
Apr 18, 2025, 18:41
Apr 18, 2025, 17:57